Antifungals and antifungal drug discovery.
Richard Calderone, William A. Fonzi, Françoise Gay‐Andrieu, Nannan Sun, Diaoguo Li, H. Chen, Deepu Alex
Abstract
Richard Calderone, William A. Fonzi, Françoise Gay‐Andrieu, Nannan Sun, Diaoguo Li, H. Chen, Deepu Alex
Abstract
Abstract This chapter discusses: (1) important clinical aspects of invasive clinical mycoses, i.e., candidosis and aspergillosis; (2) current antifungal therapeutic options for invasive mycoses; (3) antifungal drug resistance; and (4) approaches to antifungal drug discovery, including identification of drug targets.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract This chapter discusses: (1) important clinical aspects of invasive clinical mycoses, i.e., candidosis and aspergillosis; (2) current antifungal therapeutic options for invasive mycoses; (3) antifungal drug resistance; and (4) approaches to antifungal drug discovery, including identification of drug targets.
Key concepts: Antifungal, Antifungal drug, Antifungal drugs, Drug, Aspergillosis, Medicine, Drug resistance, Identification (biology)